Images
Image
Participants
Image
Contact
Image
Section Head of Communication & Outreach
Tel.+34 93 40 37255
nahia.barberia@irbbarcelona.org
Natàlia Carulla, associate researcher at IRB Barcelona devoted to studying the aggregation of the protein beta-amyloid, which is strongly associated with Alzheimer's disease, explains her approach to reveal the role of this protein in this neurodegenerative disease, a condition that affects millions of elderly people worldwide. In a study recently published in ACS Chemical Biology, Carulla describes the aggregation structures of beta-amyloid that are toxic for neurons.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
